Ledger.Open graph →
SEC Form D · filed September 21, 2018

ONL Therapeutics, Inc

Offering
$1.0M
Sold
$639K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Alexander Korff · London, United KingdomDirectorJonathan R. Asmis · San Francisco, CAExec · DirectorRobert Seidel · BURBANK, CADirectorJimmie A. Harvey, Jr · New York, NYExec · DirectorMalcolm A. Hoenlein · New York, NYDirectorJ. J. Lobell · New York, NYExec · DirectorArthur Loomis · Latham, NYExec · DirectorDan Feeney · Indianapolis, INDirectorFelicia David-Visser · Ann Arbor, MIDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗